Oncology reimbursement operates under some of the most complex and heavily scrutinized payer rules in healthcare. Drug administration, infusion services, evolving treatment protocols, and aggressive medical necessity review make generic billing models both risky and ineffective.
RevGuard provides Revenue Cycle Management purpose-built for oncology practices. Our approach focuses on upstream denial prevention, payer-aware claim construction, and dispute-ready documentation that protects reimbursement while supporting continuity of patient care.
Why Oncology Billing Breaks Down
Oncology revenue loss is often driven by:
- Drug and biologic reimbursement challenges
- Coding complexity across infusion, administration, and supportive care
- Medical necessity scrutiny tied to treatment protocols
- Authorization and documentation gaps
- Payer resistance to high-cost therapies
When these issues surface in AR, recovery becomes slow, uncertain, and operationally disruptive.
RevGuard prevents them before claims are submitted.
Oncology-Specific RCM Built Upstream
RevGuard aligns clinical documentation, coding logic, and payer requirements at the point of submission — where reimbursement decisions are made.
What We Deliver
Drug & Infusion Billing Precision
We apply oncology-specific billing logic to ensure accurate coding and reimbursement for chemotherapy, biologics, infusion services, and supportive therapies.
Medical Necessity Documentation Alignment
RevGuard ensures documentation supports payer criteria for treatment protocols, reducing subjective denials and post-payment audits.
Authorization & Payer Rule Oversight
We track payer authorization requirements and evolving coverage policies to prevent avoidable denials and retroactive non-payment.
Credentialing & Enrollment Alignment
Misaligned enrollment across providers and sites of care can quietly erode revenue. We maintain continuous alignment to eliminate payment risk.
Faster AR Without Compromising Care
Oncology practices cannot afford billing friction that delays care or disrupts operations.
RevGuard delivers:
- Reduced first-pass denial rates
- Shorter days in AR
- Fewer payer-driven delays
- More predictable reimbursement across payers
Revenue stabilizes without adding administrative burden to clinical teams.
Dispute-Ready When Payers Push Back
High-cost oncology claims are frequent targets for payer resistance.
RevGuard builds claims with Independent Dispute Resolution (IDR) readiness built in:
- Documentation supports arbitration thresholds
- Evidence is positioned for high-dollar disputes
- Offers are informed by payer behavior intelligence
- Enforcement is available when billing alone fails
This ensures leverage without compromising compliance.
Who We Support
RevGuard works with:
- Medical oncology practices
- Hematology/oncology groups
- Multi-site oncology platforms
- Hospital-affiliated oncology programs
Our systems scale across providers, sites of care, and evolving treatment models.
Why RevGuard for Oncology
Oncology revenue demands accuracy, discipline, and defensibility.
RevGuard delivers a revenue protection framework that combines specialty-specific RCM, payer intelligence, and dispute readiness — ensuring oncology practices are reimbursed accurately, consistently, and sustainably.
Two Engines. One Outcome.
Every dollar. Guarded.